Filing Flows › Cryo Cell International (CCEL) › R&D spending
Cryo Cell International (CCEL) R&D spending by quarter
Cryo Cell International's R&D spending was $54K in Q3 FY26 (third quarter fiscal 2026), -46% from Q2 FY26. Over the last 7 quarters it ranged from $54K (Q3 FY26) to $132K (Q2 FY25).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 FY26 | $54K | -46% | -13% |
| Q2 FY26 | $100K | +52% | -24% |
| Q1 FY26 | $66K | -22% | -33% |
| Q4 FY25 | $85K | +38% | — |
| Q3 FY25 | $62K | -53% | — |
| Q2 FY25 | $132K | +34% | — |
| Q1 FY25 | $98K | — | — |
Q3 FY26 at a glance
Cryo Cell International, Q3 FY26: revenue $7.8M (0% year over year), operating margin 28.0%, net earnings $1.3M, operating cash flow $1.1M. The chart follows the revenue to costs, profit and cash.
Questions
What is Cryo Cell International's R&D spending?
Cryo Cell International's R&D spending was $54K in Q3 FY26 (third quarter fiscal 2026), -46% from Q2 FY26.
How has Cryo Cell International's R&D spending changed?
Over the last 7 quarters it ranged from $54K (Q3 FY26) to $132K (Q2 FY25).
Q3 FY26 results → · How Cryo Cell International makes money →